Logo image of ORBC

Orbcomm Inc (ORBC) Stock Fundamental Analysis

NASDAQ:ORBC -

11.49
+0.01 (+0.09%)
Last: 8/31/2021, 8:42:53 PM
11.49
0 (0%)
After Hours: 8/31/2021, 8:42:53 PM
Fundamental Rating

2

ORBC gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 36 industry peers in the Diversified Telecommunication Services industry. ORBC has a bad profitability rating. Also its financial health evaluation is rather negative. ORBC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

ORBC had negative earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -8.04%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -4.21%
PM (TTM) -15.09%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

There is no outstanding debt for ORBC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

ORBC has an Altman-Z score of 1.50. This is a bad value and indicates that ORBC is not financially healthy and even has some risk of bankruptcy.
ORBC has a Debt/Equity ratio of 0.99. This is a neutral value indicating ORBC is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF N/A
Altman-Z 1.5
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

ORBC has a Current Ratio of 1.92. This is a normal value and indicates that ORBC is financially healthy and should not expect problems in meeting its short term obligations.
ORBC has a Quick Ratio of 1.50. This is a normal value and indicates that ORBC is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.92
Quick Ratio 1.5

4

3. Growth

3.1 Past

The earnings per share for ORBC have decreased by 0.00% in the last year.
Looking at the last year, ORBC shows a decrease in Revenue. The Revenue has decreased by -2.52% in the last year.
ORBC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.86% yearly.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.11%
Revenue 1Y (TTM)-2.52%
Revenue growth 3Y-0.76%
Revenue growth 5Y6.86%
Sales Q2Q%16.21%

3.2 Future

The Earnings Per Share is expected to grow by 19.64% on average over the next years. This is quite good.
ORBC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.69% yearly.
EPS Next Y59.55%
EPS Next 2Y46.31%
EPS Next 3Y27.01%
EPS Next 5Y19.64%
Revenue Next Year10.34%
Revenue Next 2Y10.09%
Revenue Next 3Y9.55%
Revenue Next 5Y9.69%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ORBC Yearly Revenue VS EstimatesORBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
ORBC Yearly EPS VS EstimatesORBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -0.2 -0.4 -0.6 -0.8

1

4. Valuation

4.1 Price/Earnings Ratio

ORBC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
ORBC is valuated quite expensively with a Price/Forward Earnings ratio of 281.62.
ORBC is valuated expensively when we compare the Price/Forward Earnings ratio to 22.52, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 281.62
ORBC Price Earnings VS Forward Price EarningsORBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 25.83
ORBC Per share dataORBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as ORBC's earnings are expected to grow with 27.01% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.31%
EPS Next 3Y27.01%

0

5. Dividend

5.1 Amount

No dividends for ORBC!.
Industry RankSector Rank
Dividend Yield N/A

Orbcomm Inc

NASDAQ:ORBC (8/31/2021, 8:42:53 PM)

After market: 11.49 0 (0%)

11.49

+0.01 (+0.09%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)N/A N/A
Earnings (Next)02-23 2022-02-23/bmo
Inst Owners0.03%
Inst Owner Change0%
Ins Owners0.6%
Ins Owner Change0%
Market Cap915.25M
Analysts46.6
Price Target11.73 (2.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 281.62
P/S 3.59
P/FCF N/A
P/OCF N/A
P/B 4.72
P/tB N/A
EV/EBITDA 25.83
EPS(TTM)-0.26
EYN/A
EPS(NY)0.04
Fwd EY0.36%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.2
BVpS2.43
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.04%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -4.21%
PM (TTM) -15.09%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.92
Quick Ratio 1.5
Altman-Z 1.5
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.11%
EPS Next Y59.55%
EPS Next 2Y46.31%
EPS Next 3Y27.01%
EPS Next 5Y19.64%
Revenue 1Y (TTM)-2.52%
Revenue growth 3Y-0.76%
Revenue growth 5Y6.86%
Sales Q2Q%16.21%
Revenue Next Year10.34%
Revenue Next 2Y10.09%
Revenue Next 3Y9.55%
Revenue Next 5Y9.69%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A